<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03926312</url>
  </required_header>
  <id_info>
    <org_study_id>SmartRehab</org_study_id>
    <nct_id>NCT03926312</nct_id>
  </id_info>
  <brief_title>Smart Device-based Cardiac Rehabilitation After Myocardial Intervention</brief_title>
  <acronym>SmartRehab</acronym>
  <official_title>Smart Device-based Cardiac Rehabilitation After Myocardial Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charles University, Czech Republic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institute for Clinical and Experimental Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charles University, Czech Republic</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the influence of cardiac rehabilitation based on smart
      band use and telemonitoring on functional capacity change and risk factors control among
      patients hospitalized for acute myocardial infarction.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">June 19, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional capacity change</measure>
    <time_frame>3 months</time_frame>
    <description>6-minute walk test distance and maximal oxygen consumption (VO2 max) change after 3 months of the intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>3 months</time_frame>
    <description>Waist circumference change after 3 months of the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body fat percentage</measure>
    <time_frame>3 months</time_frame>
    <description>Body fat percentage change after 3 months of the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Smoking cessation</measure>
    <time_frame>3 months</time_frame>
    <description>Smoking cessation after 3 months of the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipid levels</measure>
    <time_frame>3 months</time_frame>
    <description>Lipid levels change after 3 months of the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>3 months</time_frame>
    <description>Blood pressure change after 3 months of the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycated hemoglobin</measure>
    <time_frame>3 months</time_frame>
    <description>Glycated hemoglobin change after 3 months of the intervention</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Smart device-based rehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One month after myocardial infarction, patients will receive a smart band and a cellphone in order to transmit data on physical activity to electronic health record. A study nurse will periodically check compliance with recommended physical activity and intervene in the case of non-compliance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will receive a guideline directed recommendation to increase physical activity to 30 minutes of moderate physical activity a week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Smart device-based cardiac rehabilitation</intervention_name>
    <description>A smart device coupled with remote monitoring will be used to increase physical activity of patients after myocardial infarction with a history of low physical activity.</description>
    <arm_group_label>Smart device-based rehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Signed informed consent with the study

          2. Men and women &gt;18 years of age

          3. Patients ≥1 and ≤6 months after type I myocardial infarction

          4. Physical inactivity before MI defined as the absence of moderate to vigorous exercise
             for at least 30 minutes 5 or more days a week

        Exclusion Criteria:

          1. Heart failure NYHA IIIB-IV

          2. Planned coronary revascularization

          3. Planned major surgery within the next 12 months

          4. Inability to walk for any reason

          5. Comorbidities that would preclude adherence to the rehabilitation program (e.g.
             arthrosis, active malignancy, major depression or other significant psychiatric
             disorder, cognitive impairment) - at the discretion of the physician

          6. Life expectancy less than 12 months

          7. Pregnancy

          8. Inability to operate the smart-watch
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Wohlfahrt, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Clinical and Experimental Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peter Wohlfahrt, MD, PhD</last_name>
    <phone>00420739777244</phone>
    <email>wohlfp@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institute for Clinical and Experimental Medicine</name>
      <address>
        <city>Prague</city>
        <state>CZEC</state>
        <zip>14021</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Wohlfahrt, MD, PhD</last_name>
      <phone>420739777244</phone>
      <phone_ext>420739777244</phone_ext>
    </contact>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>April 21, 2019</study_first_submitted>
  <study_first_submitted_qc>April 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2019</study_first_posted>
  <last_update_submitted>June 19, 2019</last_update_submitted>
  <last_update_submitted_qc>June 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institute for Clinical and Experimental Medicine</investigator_affiliation>
    <investigator_full_name>Peter Wohlfahrt</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>myocardial infarction</keyword>
  <keyword>cardiac rehabilitation</keyword>
  <keyword>smart device</keyword>
  <keyword>remote monitoring</keyword>
  <keyword>telemonitoring</keyword>
  <keyword>low physical activity</keyword>
  <keyword>risk factors control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

